In part two of this three-part discussion, Adam and Dennis discuss the key barriers for entry for companies expanding into new territories and how to overcome these, whether you're a start-up or established company entering the market.

Dennis brings insight from his broad and brilliant background in molecular oncology and precision medicine, with experience in all elements from research to pharma and commercial. Discussing the challenges and opportunities he's faced as the CEO of Predicine in Europe.

This conversation comes in three parts. In part one, the pair discussed the importance of liquid biopsy for the future oncology market. Part three discusses new liquid biopsy technologies and what's new at Predicine. Be sure to subscribe to be notified when all parts are available.

If you'd like to get in touch about this episode, be a future podcast guest, or learn more about CM Life Science's services, please email Adam at [email protected].

Hosted on Acast. See acast.com/privacy for more information.

In this episode of Diagnostics Digest, Adam speaks to Dennis Merkle, CEO of Europe and Global Head of Biopharma Business for molecular insights company, Predicine.

Dennis brings insight from his broad and brilliant background in molecular oncology and precision medicine, with experience in all elements from research to pharma and commercial. Here we jump into a well-rounded discussion on the benefits of liquid biopsy in today's oncology market.

This conversation comes in three parts. In part two, we delve into critical barriers within the market and how to overcome these. Part three discusses new liquid biopsy technologies and what's new at Predicine. Be sure to subscribe to be notified when all parts are available.

If you'd like to get in touch about this episode, be a future podcast guest, or learn more about CM Life Science's services, please email Adam at [email protected].

Hosted on Acast. See acast.com/privacy for more information.

In this episode of Diagnostics Digest, a CM Life Science series discussing trends and insights into the diagnostics market, I speak with Beth Cobb, Chief Operating Officer at NOWDiagnostics | NowDx.

NOWDx is on a mission to develop rapid, accurate, affordable, and easy-to-administer over-the-counter and point-of-care diagnostic tests that return results in minutes. This innovative product is accompanied by a vision to create a world with vastly improved access to accurate healthcare information. Through providing access to quick and easy at home testing, patients and caregivers become empowered with the knowledge and understanding to truly change the future of disease management.

In this episode, we discuss diversity and gender equality in the start-up and diagnostics space, and what this landscape means for the future of NOWDx and others in the market. Priding themselves on striving to make a difference to people's lives, both colleagues and customers, Beth delves into the challenges and strategies she has experiences when doing just that.

Whether you’re in the diagnostics industry or not, this episode promises invaluable insight for those looking to change their company DEI agenda for the better.

If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself or want to learn more about CM Life Science's services; then please drop me a message at [email protected] or let's connect on LinkedIn.

Hosted on Acast. See acast.com/privacy for more information.

In this episode of Diagnostics Digest, a CM Life Science series discussing trends and insights into the diagnostics market, I speak with Wendy Harman, Vice President of Product and Commercial at Weavr Health.

After being selected as one of the Built In Boston 'Best Small Companies To Work For', and announcing its recent Labcorp partnership, we discuss the successes and challenges of retaining a core company culture when scaling a fast-growing start-up. From how to build a company culture that attracts the best talent, to what makes their innovative approaches and technologies different to others in the market, Wendy shares plenty of insight you won't want to miss. Wendy also discusses Weavr’s

partnership with Nightingale Health, who recently announced the availability of the Livit service to the UK.

Whether you’re in the diagnostics industry or not, this episode has some invaluable info for those looking to change an industry's approach to company culture.

If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself or want to learn more about CM Life Science's services; then please drop me a message at [email protected] or let's connect on LinkedIn.

Hosted on Acast. See acast.com/privacy for more information.